The 18th meeting of the Member State Coordination Group on Health Technology Assessment established by Regulation (EU) 2021/2282 was held on 12 February 2026 in Brussels. Representatives from all Member States joined the meeting, as...
The document provides answers to questions asked by stakeholders on the Joint Clinical Assessment (JCA) process. Read the background document published by DG Health and Food Safety on 18 May 2026.
The document, based on enquiries received, provides answers to questions asked by stakeholders on the Joint Clinical Assessment (JCA) process. In addition, general learnings from JCA are included in the document. Read the background document published...
The document provides answers to questions frequently asked by stakeholders related to Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU...
The purpose of this document is to provide general principles to be used when assessing the requests for confidentiality from health technology developers in the context of joint clinical assessments. The specific circumstances in relation...
The SoHO Coordination Board meeting was attended by members and alternates from all Member States and observers from NO, LI and IS, the European Directorate for the Quality of Medicines (EDQM) and the European Centre...
The enhanced EU Health Policy Platform (HPP) introduces a range of exciting updates to the EU HPP, a thriving community of over 8 250 health stakeholders. These improvements are designed to boost accessibility, increase visibility,...
This EUHPP Live Webinar is the first webinar of the Thematic Network PEITHO (Platform for European Interdisciplinary, Transdisciplinary, Holistic One Health). Its purpose is to gather input for a joint statement, a collaborative document intended...
The European Health and Digital Executive Agency (HaDEA) has signed two new contracts under the 2025 EU4Health work programme: support for the implementation of the new Substances of Human Origin (SoHO) Regulation, and support for...
This Q&A document is intended to facilitate the application of Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 (MDR) and (EU) 2017/746 (IVDR) as...
